SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-021371
Filing Date
2018-08-03
Accepted
2018-08-03 16:05:37
Documents
2
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1625
2 EX-24 DOCUMENT attachment1.htm EX-24 3095
  Complete submission text file 0000899243-18-021371.txt   6315
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10

Mailing Address C/O CORNERSTONE THERAPEUTICS INC 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address
Price David (Reporting) CIK: 0001449336 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 18991842